C0281666||alitretinoin
C0087111||treatment
C2246986||skin barrier
C0017262||gene
C1171362||protein expression
C1276092||chronic hand eczema
C1276092||Chronic hand eczema
C1276092||Chronic hand eczema
C3875321||inflammatory skin disease
C1257890||population
C0281666||alitretinoin
C1276092||Chronic hand eczema
C0304604||topical corticosteroids
C0281666||alitretinoin
C2246986||skin barrier
C0017337||genes
C1171362||protein expression
C0037284||skin lesions
C1276092||Chronic hand eczema
C1276092||Chronic hand eczema
C0332293||treated with
C0281666||alitretinoin
C0150866||Skin biopsies
C0220825||evaluated
C0087111||therapy
C1171362||expression
C0208804||Ki-67
C2246986||skin barrier
C0017337||genes
C0762640||thymic stromal lymphopoietin
C0762640||thymic stromal lymphopoietin
C3179034||real-time quantitative polymerase chain reaction
C0021044||immunohistochemistry
C0281666||alitretinoin
C1276092||Chronic hand eczema
C0936012||Analysis
C0150866||skin biopsies
C0087111||treatment
C1334508||Ki-67
C1514241||positive
C0007634||cells
C0243092||suprabasal layer
C0017263||dysregulated expression
C2246986||skin barrier
C0017337||genes
C1413460||claudin 1
C1416897||loricrin
C1414633||filaggrin
C1416714||cytokeratin 10
C1882115||normalized
C0087111||treatment
C0762640||thymic stromal lymphopoietin
C0041904||upregulated
C1276092||Chronic hand eczema
C1882115||normalized
C0281666||alitretinoin
C0087111||treatment
C1513916||negatively
C0117738||filaggrin
C0017337||genes
C0033684||proteins
C1882115||normalized
C0087111||treatment
C0281666||alitretinoin
C1276092||Chronic hand eczema
C0017262||expression
C0017337||genes
C0281666||alitretinoin
C0012634||disease
C0762640||thymic stromal lymphopoietin
C0041904||upregulated
C1276092||Chronic hand eczema
C0117738||filaggrin
C1171362||expression
C1123023||skin